Friday, 2 October 2026
Friday, 2 October 2026
- In brief
- 1People who use cannabis were about twice as likely to commit violence, in a review of 63 studies of more than 265,000 people
- 2Pennsylvania counts five measles deaths
- 3A three-hormone weight-loss drug passes a big trial
- 4Half the world breathed bad ozone
- 5Phoenix heat deaths up 76%
- 6Sedating drugs in dementia care
- 7WHO: 45% of dementia risk can be changed
- 8A joint supplement and Alzheimer's
- 9Menopause supplements no better than a multivitamin
- 10Most IVF extras lack evidence
- 11Melanoma patients alive five years on
- 12Jehovah's Witnesses may now accept donor blood parts
- 13CDC survey would drop disability questions
- 14A two-year minimum wait for ADHD tests
- 15Science devotes an issue to women's health
- 16A US report on transgender care, unreviewed
- 17Kennedy wants health records searched by AI
- 18Psilocybin tied the brain to its setting
- 19Sounds during sleep moved brain fluid
- 20Organs look youngest on about seven hours' sleep
- 21One malaria drug does most of the work
- 22How Ozempic's drug protects kidneys is still open
- 23CPAP lowered signs of inflammation
- 24Arthritis pain that outlasts the inflammation
- 25Social anxiety and the habits that feed it
- 26Weekend exercise and arthritis
- 27Emotion, recorded one brain cell at a time
- 28Implants that talk through the body
- 29A father rat's early stress showed up in his daughters
2 Oct · Mind & body · In brief
Mind & body · Friday, 2 October 2026
Mind & body, in brief
29 stories · 38 sources
Swipe up for the day in brief ↑Scroll down for the day in brief ↓
What is moving · 1 of 4
Products sold before proof
Which?, a British consumer group, found none of 26 menopause supplements had the right nutrients in the right doses.
What is moving · 2 of 4
US health numbers in dispute
Pennsylvania, a US state, counts five measles deaths this year, while the national CDC lists two for the whole country.
What is moving · 3 of 4
Hot nights and dirty air
Phoenix, a US city, had 29 nights this year that stayed above 90F (32C), against about seven in a usual year.
What is moving · 4 of 4
Drugs that act on the brain
THC in Danish cannabis resin nearly quadrupled between 2000 and 2022.
13 sources
Mind & body, in brief
- 2Changes in cannabis potency and cannabis-related psychiatric harms: a 23-year ecological study in Denmark
- 5Pennsylvania reports fifth measles-related death of the year amid outbreak
- 6Travel plans? Here's what to know as measles exposures reach trains and games
- 10Dangerous ozone threatened half of world's population this year
- 11Heat-related deaths in Phoenix rise, after two years of decline
- 12Drugs are widely used to sedate dementia patients. Her sons wanted to keep her off them
- 13New WHO guidelines: up to 45% of dementia risk could be prevented or delayed
- 14Hyperglycosylation is a metabolic driver of Alzheimer's disease
- 16Menopause supplements costing more than 400 pounds a year 'no better than cheap multivitamin'
- 17IVF 'add-ons' offer hope to parents desperate for a baby. But are they backed by science?
- 20As CDC redesigns annual health survey, it removes questions about disabilities
- 23What's behind HHS claims that gender-affirming care 'may' radicalize
- 25Embeddedness under psilocybin
People who use cannabis were about twice as likely to commit violence, in a review of 63 studies of more than 265,000 people
Swipe up for the story ↑Scroll down for the story ↓
A team at King's College London's psychiatry institute pooled 63 studies of more than 265,000 people.
Cannabis users were about twice as likely as non-users to have committed violence.
announced on 1 October and published in the journal Psychological Medicine
the link was stronger for women than for men
Who is involved
Marta Di Forti
a professor of drug use, genetics and psychosis at King's College London; she says a review this size lets researchers speak with more confidence, without stigmatising cannabis users
Who is involved
Robin Murray
a professor of psychiatric research quoted in the review's announcement; he says violence, done and suffered, belongs in the debate about cannabis
Why it matters
Watch whether new studies measure how much cannabis people use and how strong it is, which the review could not do, and whether mental health services add cannabis to their violence risk checks.
What's really going on
A review from King's College London found cannabis users about twice as likely to commit violence, but it cannot say cannabis caused it, and most of its 63 studies came before today's much stronger cannabis.
Who pays
Cannabis users themselves
They were about one and a half times as likely to be victims of violence, and the link was stronger for women.
Nobody knows yet
Whether cannabis causes violence, or only travels with things that do.
The review pooled studies that observed people, and other drugs, alcohol and hard circumstances go with both cannabis use and violence. The link was smaller in studies that followed people over time.
Nobody knows yet
How much bigger the risk is with today's stronger cannabis.
Few of the 63 studies measured how much people used, and most came before high-strength cannabis was common. THC in Danish resin nearly quadrupled between 2000 and 2022.
The short version
That's the story in short.
The whole story has 13 more parts.
or swipe up for the next storyor scroll on for the next story ↓
The whole story, in 13 parts ↓
Part 1 of 13 · Who else is involved
King's College London's Institute of Psychiatry, Psychology and Neuroscience
a London research institute; its team pooled the 63 studies
Part 1 of 13 · Who else is involved
The Cannabis Clinic for Patients with Psychosis
a south London NHS clinic led by Di Forti for people with psychosis who want to cut down; it takes 16 people at a time
Part 2 of 13 · How it unfolded
Feb 2026
a US study of 460,000 teenagers ties past-year cannabis use to twice the risk of psychotic and bipolar disorders
1 Oct 2026
the review of cannabis and violence is announced
Part 3 of 13
Among people in psychiatric care, users were about two and a half times as likely to be violent as patients who did not use cannabis.
Part 4 of 13
For violence that led to a criminal conviction, users were three to four times as likely to be convicted, but only a few studies measured convictions.
Part 5 of 13
Users were also about one and a half times as likely to be victims of violence.
Part 5 of 13
That link was stronger for women than for men.
Part 6 of 13
The review counted physical, sexual and psychological violence, inside and outside relationships, using the World Health Organization's broad definition.
Part 7 of 13
The link held in studies that followed people over time.
Part 7 of 13
It was smaller there than in studies that looked at a single moment.
Part 8 of 13
The review shows a link, not a cause.
Part 8 of 13
Other drugs, alcohol and hard circumstances often go with cannabis use, and they may raise the risk of violence too.
Part 9 of 13
Few of the studies measured how much or how often people used cannabis.
Part 9 of 13
Most were done before high-strength cannabis became common.
Part 10 of 13
In Denmark, THC, the main mind-altering chemical in cannabis, rose from 8.3% to 31.2% of seized cannabis resin between 2000 and 2022.
Part 11 of 13
In a Danish national records study, years with stronger cannabis went with more diagnoses of psychosis caused by cannabis.
Part 12 of 13
An earlier King's study, from 2019, linked 12% of new psychosis cases in 11 European places to high-strength cannabis, and 30% in London.
Part 13 of 13
The review's authors want mental health services to ask about cannabis when they judge someone's risk of violence.
Part 13 of 13
They also want public health messages about cannabis to mention violence.
3 sources
People who use cannabis were about twice as likely to commit violence, in a review of 63 studies of more than 265,000 people
The full story
People who use cannabis were about twice as likely to commit violence, in a review of 63 studies of more than 265,000 people
A team at King's College London's psychiatry institute pooled 63 studies of more than 265,000 people.
Among people in psychiatric care, users were about two and a half times as likely to be violent as patients who did not use cannabis.
For violence that led to a criminal conviction, users were three to four times as likely to be convicted, but only a few studies measured convictions.
Users were also about one and a half times as likely to be victims of violence. That link was stronger for women than for men.
The review counted physical, sexual and psychological violence, inside and outside relationships, using the World Health Organization's broad definition.
The link held in studies that followed people over time. It was smaller there than in studies that looked at a single moment.
The review shows a link, not a cause. Other drugs, alcohol and hard circumstances often go with cannabis use, and they may raise the risk of violence too.
Few of the studies measured how much or how often people used cannabis. Most were done before high-strength cannabis became common.
In Denmark, THC, the main mind-altering chemical in cannabis, rose from 8.3% to 31.2% of seized cannabis resin between 2000 and 2022.
In a Danish national records study, years with stronger cannabis went with more diagnoses of psychosis caused by cannabis.
An earlier King's study, from 2019, linked 12% of new psychosis cases in 11 European places to high-strength cannabis, and 30% in London.
The review's authors want mental health services to ask about cannabis when they judge someone's risk of violence. They also want public health messages about cannabis to mention violence.
Why it matters. Watch whether new studies measure how much cannabis people use and how strong it is, which the review could not do, and whether mental health services add cannabis to their violence risk checks.
Pennsylvania counts five measles deaths
Swipe up for the story ↑Scroll down for the story ↓
Pennsylvania, a US state, reported its fifth measles-linked death of 2026 on 30 September: an unvaccinated person in Lancaster county.
Its outbreak has reached 943 confirmed cases and 176 hospital stays across 39 counties.
The US Centers for Disease Control and Prevention (CDC), the national disease agency, listed more than 3,600 cases nationwide but two deaths.
In early September the CDC said it would count measles deaths from official death records, rather than relying only on state reports, breaking with past practice.
Why it matters
Pennsylvania asked the CDC for emergency help and said it could withdraw the request unless the agency recognises the state's deaths.
Why it matters
Robert F Kennedy Jr, the US health secretary, first called the state's announcement premature.
Who pays
Unvaccinated communities in Pennsylvania
The outbreak has reached 943 cases, 176 hospital stays and five deaths, centred on farming areas of Lancaster and Mifflin counties.
Nobody knows yet
How many people have died of measles in the US this year.
Pennsylvania counts five deaths in its own outbreak, while the CDC lists two nationwide and now waits for official death records instead of state reports.
Good news
Pennsylvania's state health centres have given more than 5,500 measles vaccinations at 180 pop-up clinics since the outbreak began in April.
The full story
Pennsylvania counts five measles deaths
Pennsylvania, a US state, reported its fifth measles-linked death of 2026 on 30 September: an unvaccinated person in Lancaster county.
Why it matters. Pennsylvania asked the CDC for emergency help and said it could withdraw the request unless the agency recognises the state's deaths.
A three-hormone weight-loss drug passes a big trial
Swipe up for the story ↑Scroll down for the story ↓
Retatrutide, an experimental drug made by Eli Lilly, copies three gut hormones that help control hunger, blood sugar and energy use.
Wegovy, an existing weight-loss drug, copies one of them, and Mounjaro copies two.
In an 80-week trial of 1,152 adults with obesity and type 2 diabetes, people on the top weekly dose lost 18.8% of their body weight, against 5.1% on a dummy injection.
The results were published in the Lancet.
Why it matters
Diarrhoea affected 27-34% of people on the drug, against 13% on the dummy, and Lilly paid for the study.
Why it matters
It is the first drug acting on three of these hormones to be tested in a phase 3 trial, the large test US regulators need before they will consider approving a drug.
How it works
Why what a product is sold as decides whether it needs a trial
How it works
A product sold as a medicine must pass trials before it is approved, but one sold as a food supplement or a clinic's extra can go on sale without one.
How it works · step 1 of 5
A health product is sold as a medicine, a food supplement or a clinic's extra
How it works · step 2 of 5
A medicine must pass large trials before regulators will consider it
How it works · step 3 of 5
A supplement falls under food rules, and clinics sell IVF extras while competing for patients
How it works · step 4 of 5
So supplements and extras reach buyers without a trial showing they help
How it works · step 5 of 5
Checks come later, if someone pays for them, and often find little benefit or a harm
The twist
The buyer of a menopause blend and the buyer of a weight-loss drug both hope it will help.
The twist
Only the drug has to show in a trial that it does before it can be sold.
The picture
Retatrutide had to pass a trial in 1,152 people before Eli Lilly could ask for approval. Menopause supplements in Britain sell under food rules, and Which? checked 26 only after they were on shelves.
Seen the same day
They went on sale under food rules first, and Which? tested 26 of them only afterwards.
Seen the same day
Clinics sold the extras to patients paying their own money, and a review of 10 came after they were in wide use.
Seen the same day
Sold over the counter under lighter US rules than prescription drugs, its possible harm in dementia turned up in health records, not in a trial before sale.
Seen the same day
The other route: as a medicine, retatrutide had to finish a phase 3 trial in 1,152 people before Lilly can ask regulators to approve it.
The catch
A missing trial does not mean a product fails. Calcium and vitamin D do matter at menopause, and the WHO's dementia advice still allows vitamins for people who lack them.
The whole
A woman choosing a menopause blend, a couple paying for IVF extras and a regulator reading Lilly's trial all act inside rules that were set long before any of them arrived.
The whole
None of them decided which set of rules the product would fall under.
Who gains
Eli Lilly
Its retatrutide is the first drug acting on three gut hormones to be tested in a phase 3 trial, and it plans to seek approval early next year.
Nobody knows yet
How much weight people on retatrutide's top dose really lost.
Scientific American, quoting Eli Lilly, gives 49.6 pounds (22.5 kg), more than 20% of body weight. The Guardian, reporting the Lancet paper, gives an average of 18.8%. Neither report explains the gap.
Good news
On the top dose of retatrutide, 72 in every 100 people with type 2 diabetes brought their long-term blood sugar down to 6.5% or below, against 29 in 100 on a dummy injection.
2 sources
A three-hormone weight-loss drug passes a big trial
The full story
A three-hormone weight-loss drug passes a big trial
Retatrutide, an experimental drug made by Eli Lilly, copies three gut hormones that help control hunger, blood sugar and energy use.
Why it matters. Diarrhoea affected 27-34% of people on the drug, against 13% on the dummy, and Lilly paid for the study.
Half the world breathed bad ozone
Swipe up for the story ↑Scroll down for the story ↓
51 of 100
people out of every 100 who breathed very poor or worse ozone
About 51% of the world's people breathed 'very poor' or 'extremely poor' levels of ground-level ozone over the past six months, the Copernicus Atmosphere Monitoring Service, which tracks air quality worldwide, said on 29 September.
Both levels are above the World Health Organization's limits.
Near the ground it is the main part of smog and can damage the lungs.
Why it matters
Asia was worst, with 75% of people exposed to at least very poor levels.
Why it matters
The gases that make ozone cross borders, which makes it harder for any one country to cut.
1 source
Half the world breathed bad ozone
The full story
Half the world breathed bad ozone
About 51% of the world's people breathed 'very poor' or 'extremely poor' levels of ground-level ozone over the past six months, the Copernicus Atmosphere Monitoring Service, which tracks air quality worldwide, said on 29 September.
51 of 100
people out of every 100 who breathed very poor or worse ozone
Why it matters. Asia was worst, with 75% of people exposed to at least very poor levels.
Phoenix heat deaths up 76%
Swipe up for the story ↑Scroll down for the story ↓
Maricopa County, which includes Phoenix in the US state of Arizona, has confirmed 275 heat deaths so far this year, 76% more than at this point last year.
More than 500 other deaths are still being checked.
The county's medical examiner says nights that stay above 90F (32C) several days in a row seem riskiest; Phoenix had 29 such nights this year.
Why it matters
Officials count all of these deaths as preventable.
Nobody knows yet
How many of the 500 deaths still being checked in Maricopa County will count as heat deaths.
The medical examiner does not expect this year to beat the 2023 record of 645, but the checks are not finished.
The full story
Phoenix heat deaths up 76%
Maricopa County, which includes Phoenix in the US state of Arizona, has confirmed 275 heat deaths so far this year, 76% more than at this point last year.
Why it matters. Officials count all of these deaths as preventable.
Sedating drugs in dementia care
Swipe up for the story ↑Scroll down for the story ↓
Medicare is the US government's health insurance for people aged 65 or over.
About one in four people with dementia on Medicare may be getting antipsychotics or other brain-altering drugs that are not right for them, a study in JAMA estimated.
Antipsychotics are approved mainly for schizophrenia, and the US Food and Drug Administration warns they raise the risk of death in older people with dementia.
NPR reported on Marjorie Tingley, 85, whose Michigan care home pushed to sedate her and then gave her an eviction notice.
Why it matters
Her sons are suing, and the care home denies their claims.
Why it matters
Nearly half of the 1 million people in US assisted living have dementia, and families there can face a choice between agreeing to the drugs and losing the place.
Who gains
Care homes that sedate agitated residents
Sedated residents are easier to look after, one son alleged; the Michigan home he is suing calls the drugs routine medication.
Who pays
People with dementia in US care and their families
Families can face a choice between agreeing to sedating drugs that carry a death warning and losing the place.
2 sources
Sedating drugs in dementia care
The full story
Sedating drugs in dementia care
Medicare is the US government's health insurance for people aged 65 or over.
Why it matters. Her sons are suing, and the care home denies their claims.
WHO: 45% of dementia risk can be changed
Swipe up for the story ↑Scroll down for the story ↓
On 15 July the World Health Organization (WHO) updated its guidelines on lowering the risk of dementia, the first update since 2019.
It says up to 45% of dementia risk is linked to things that can change, such as smoking, alcohol, loneliness, inactivity, high blood pressure and air pollution.
It newly recommends cutting exposure to air pollution, and says hearing aids may be offered.
It does not recommend vitamin B or E, omega-3 or multivitamin pills for this, unless a person lacks them.
Why it matters
More than 57 million people live with dementia, and nearly 10 million are diagnosed each year.
Why it matters
It costs the world about US$1.3 trillion a year, and about half of that is unpaid care by families.
1 source
WHO: 45% of dementia risk can be changed
The full story
WHO: 45% of dementia risk can be changed
On 15 July the World Health Organization (WHO) updated its guidelines on lowering the risk of dementia, the first update since 2019.
Why it matters. More than 57 million people live with dementia, and nearly 10 million are diagnosed each year.
A joint supplement and Alzheimer's
Swipe up for the story ↑Scroll down for the story ↓
Glucosamine is a supplement widely sold for joint health, and in the US it is regulated less strictly than prescription drugs.
In June a team writing in Nature Metabolism reported that brains with Alzheimer's disease carry too many sugar chains on their proteins.
Giving glucosamine, which the body uses to build those chains, made memory problems worse in mice bred to get the disease.
In University of Florida health records, people with dementia who took glucosamine had a 25% higher risk of dying.
Why it matters
Health records show a link, not a cause, and the higher death risk did not show up in people with milder memory loss.
Why it matters
The researchers say the sugar-chain build-up could become a target for treatment.
How it works
Sold over the counter under lighter US rules than prescription drugs, its possible harm in dementia turned up in health records, not in a trial before sale.
The idea, in story 3: Why what a product is sold as decides whether it needs a trial →Nobody knows yet
Whether glucosamine harms people who already have dementia.
The evidence is mouse experiments and a link in US health records, with no trial, and the higher death risk did not appear in people with milder memory loss.
2 sources
A joint supplement and Alzheimer's
The full story
A joint supplement and Alzheimer's
Glucosamine is a supplement widely sold for joint health, and in the US it is regulated less strictly than prescription drugs.
Why it matters. Health records show a link, not a cause, and the higher death risk did not show up in people with milder memory loss.
Menopause supplements no better than a multivitamin
Swipe up for the story ↑Scroll down for the story ↓
Which?, a British consumer group, checked 26 supplements sold for menopause by shops such as Boots, Holland & Barrett and Amazon.
None held the right nutrients in the right doses to back their use for menopause.
The dearest, at £485 a year, contained no calcium or magnesium, while an Asda multivitamin at £22 a year held both.
Calcium and vitamin D matter most at menopause, because they support bones as oestrogen falls.
Why it matters
A trade body for the makers said food supplements must follow the food rules that apply to them.
Why it matters
A separate UCL check of 201 such products found fewer than half contained vitamin D and calcium.
How it works
They went on sale under food rules first, and Which? tested 26 of them only afterwards.
The idea, in story 3: Why what a product is sold as decides whether it needs a trial →What's really going on
Elsewhere today, checks made only after products were on sale found little benefit in menopause supplements and most IVF extras, and a possible harm from the joint supplement glucosamine in people with dementia.
Who gains
Makers of menopause supplements
Products costing up to £485 a year sell under food rules, though Which? found none had the right nutrients in the right doses.
Who pays
Women buying menopause supplements
The dearest blend Which? checked cost £485 a year and had no calcium or magnesium; a £22 multivitamin had both.
3 sources
Menopause supplements no better than a multivitamin
The full story
Menopause supplements no better than a multivitamin
Which?, a British consumer group, checked 26 supplements sold for menopause by shops such as Boots, Holland & Barrett and Amazon.
Why it matters. A trade body for the makers said food supplements must follow the food rules that apply to them.
Most IVF extras lack evidence
Swipe up for the story ↑Scroll down for the story ↓
IVF clinics sell extras such as tests of embryos' chromosomes, growth hormone shots and blood-plasma injections.
- Little or no effect on births3 · 30%
- Mixed or weak evidence4 · 40%
- A possible benefit3 · 30%
Surveys in Britain and Australia found at least three in four IVF patients had tried one.
A review of 10 popular extras found three made little or no difference to the chance of a baby, four had mixed or weak evidence, and three showed a possible benefit.
One US patient, Alessandra Dowling, estimates she spent close to $200,000 on fertility care including extras.
Why it matters
In the US, insurance rarely covers IVF and the national health research agency long restricted embryo studies.
Why it matters
So research on the extras happens in a setting much more driven by market forces, with clinics competing, said Marcelle Cedars, a fertility doctor at the University of California, San Francisco.
How it works
Clinics sold the extras to patients paying their own money, and a review of 10 came after they were in wide use.
The idea, in story 3: Why what a product is sold as decides whether it needs a trial →Why it works on people
People in distress will pay for a small chance: one IVF patient said that with the extras, 'you're paying for hope'.
Who gains
IVF clinics selling extras
Patients pay for extras out of their own pockets, and a review found three of 10 popular ones made little or no difference to births.
1 source
Most IVF extras lack evidence
The full story
Most IVF extras lack evidence
IVF clinics sell extras such as tests of embryos' chromosomes, growth hormone shots and blood-plasma injections.
- Little or no effect on births3 · 30%
- Mixed or weak evidence4 · 40%
- A possible benefit3 · 30%
Why it matters. In the US, insurance rarely covers IVF and the national health research agency long restricted embryo studies.
Melanoma patients alive five years on
Swipe up for the story ↑Scroll down for the story ↓
A study in Nature Medicine pooled 1,038 patients from 26 centres with advanced melanoma, a skin cancer, that could still be removed by surgery.
Most got immune drugs, which help the body attack the cancer, before their operation.
Among patients whose tumour had largely died off by the time of surgery, about 98% were alive.
Why it matters
Those patients gained nothing from staying on the drugs after surgery.
Good news
In a study of 1,038 people with advanced melanoma, a skin cancer, those whose tumours had largely died off on immune drugs before surgery were about 98 in 100 alive five years later.
1 source
Melanoma patients alive five years on
The full story
Melanoma patients alive five years on
A study in Nature Medicine pooled 1,038 patients from 26 centres with advanced melanoma, a skin cancer, that could still be removed by surgery.
Why it matters. Those patients gained nothing from staying on the drugs after surgery.
Jehovah's Witnesses may now accept donor blood parts
Swipe up for the story ↑Scroll down for the story ↓
Jehovah's Witnesses, a religious group, have refused blood transfusions under a rule dating from 1945.
Since 18 September members may decide for themselves whether to accept red cells, white cells, platelets or plasma from a donor, according to a letter in the BMJ on 30 September.
A March update had already left the use of a patient's own stored blood to personal conscience.
Why it matters
For decades hospital records have carried 'no blood' alerts that assumed a Witness would refuse all four blood parts.
Good news
Since 18 September, Jehovah's Witnesses may decide for themselves whether to accept red cells, white cells, platelets or plasma from a donor.
1 source
Jehovah's Witnesses may now accept donor blood parts
The full story
Jehovah's Witnesses may now accept donor blood parts
Jehovah's Witnesses, a religious group, have refused blood transfusions under a rule dating from 1945.
Why it matters. For decades hospital records have carried 'no blood' alerts that assumed a Witness would refuse all four blood parts.
CDC survey would drop disability questions
Swipe up for the story ↑Scroll down for the story ↓
The US National Health Interview Survey has asked Americans about their health every year since 1957.
A redesign proposed in August by the CDC's statistics centre would cut its questions from 482 to 150.
It drops questions on hearing aids, tiredness, thinking, and wheelchairs or scooters, though more than a quarter of Americans have a disability.
The US health department said the changes were driven by the cost of collecting data.
Why it matters
A paper co-written by CDC statisticians found the survey may already miss 75% of people with intellectual and developmental disabilities.
Nobody knows yet
Whether the CDC's survey redesign goes ahead as proposed.
It was only proposed in August, and the US health department gave the cost of collecting data as its reason without saying why disability questions were the ones cut.
1 source
CDC survey would drop disability questions
The full story
CDC survey would drop disability questions
The US National Health Interview Survey has asked Americans about their health every year since 1957.
Why it matters. A paper co-written by CDC statisticians found the survey may already miss 75% of people with intellectual and developmental disabilities.
A two-year minimum wait for ADHD tests
Swipe up for the story ↑Scroll down for the story ↓
The NHS board for West Yorkshire, covering Leeds, Bradford and three other areas of England, now makes people wait at least two years for an ADHD or autism assessment.
ADHD is attention deficit hyperactivity disorder.
It says the board broke equality law and patients' right to choose another provider.
Why it matters
Three other English boards have set minimum waits and 11 ration assessments in other ways, as costs rise with demand.
Why it matters
A government review led by Prof Peter Fonagy is expected to suggest support without a formal diagnosis first.
Who pays
People waiting for ADHD or autism assessments in West Yorkshire
They must now wait at least two years, a rule set without published reasons or public consultation, ADHD UK says.
Nobody knows yet
Whether West Yorkshire's two-year minimum wait for ADHD assessments is lawful.
ADHD UK has threatened a judicial review, and the NHS board has declined to comment while legal action is possible.
1 source
A two-year minimum wait for ADHD tests
The full story
A two-year minimum wait for ADHD tests
The NHS board for West Yorkshire, covering Leeds, Bradford and three other areas of England, now makes people wait at least two years for an ADHD or autism assessment.
Why it matters. Three other English boards have set minimum waits and 11 ration assessments in other ways, as costs rise with demand.
Science devotes an issue to women's health
Swipe up for the story ↑Scroll down for the story ↓
Science, a leading research journal, published a special issue on women's health on 1 October.
One review looks at why women have pain with no clear injury behind it at about twice the rate of men, pointing to sex hormones, links between immune cells and nerves, and gut bacteria.
Another argues that the X and Y chromosomes shape ageing and disease enough to be considered whenever treatments are matched to each patient.
Why it matters
The editors named funding cuts to women's health research as one reason for the issue.
Why it matters
One editor said heart and metabolic disease were left out because too little is yet known about how sex changes them.
1 source
Science devotes an issue to women's health
The full story
Science devotes an issue to women's health
Science, a leading research journal, published a special issue on women's health on 1 October.
Why it matters. The editors named funding cuts to women's health research as one reason for the issue.
A US report on transgender care, unreviewed
Swipe up for the story ↑Scroll down for the story ↓
In August the US health department published a report suggesting that support for gender-affirming care, the accepted medical care for transgender people, may go with support for political violence.
It was not peer reviewed, and its data and funding have not been released.
Liliana Mason, a political psychologist at Johns Hopkins University, said she would recommend rejecting it.
Why it matters
A large body of evidence shows transgender people are far more often victims of violence than perpetrators, NPR reported.
Why it matters
Co-author Colin Wright said the report will be sent to a journal.
1 source
A US report on transgender care, unreviewed
The full story
A US report on transgender care, unreviewed
In August the US health department published a report suggesting that support for gender-affirming care, the accepted medical care for transgender people, may go with support for political violence.
Why it matters. A large body of evidence shows transgender people are far more often victims of violence than perpetrators, NPR reported.
Kennedy wants health records searched by AI
Swipe up for the story ↑Scroll down for the story ↓
Robert F Kennedy Jr, the US health secretary, said on 28 September that Americans' medical and lifestyle records should be joined up and searchable by AI.
He named vaccines, food and chemicals as things to test against chronic illness and autism.
He said officials already use records from Medicaid, a US government health scheme with tens of millions of children in it, and a CDC vaccine-safety database.
He spoke at an event run by the Maha Institute, a group whose head has called himself an anti-vaxxer.
Why it matters
Kennedy is a long-time vaccine sceptic, and officials have set up an autism registry despite wide protest.
1 source
Kennedy wants health records searched by AI
The full story
Kennedy wants health records searched by AI
Robert F Kennedy Jr, the US health secretary, said on 28 September that Americans' medical and lifestyle records should be joined up and searchable by AI.
Why it matters. Kennedy is a long-time vaccine sceptic, and officials have set up an autism registry despite wide protest.
Psilocybin tied the brain to its setting
Swipe up for the story ↑Scroll down for the story ↓
Psilocybin is a psychedelic drug.
A study in Nature scanned 62 people who had never taken a psychedelic, before and after a dose, while they rested, meditated, listened to music and watched a film.
On the drug, their brain activity lined up more closely with what they were doing.
The effect was strongest in people who said the line between themselves and the world faded, and it predicted shifts in their mindset the next day.
Why it matters
The stronger effect did not go with anxiety or confusion.
The full story
Psilocybin tied the brain to its setting
Psilocybin is a psychedelic drug.
Why it matters. The stronger effect did not go with anxiety or confusion.
Sounds during sleep moved brain fluid
Swipe up for the story ↑Scroll down for the story ↓
During deep sleep, the fluid around the brain and spinal cord moves in large waves, in time with slow brain waves.
Levitt and colleagues played sounds to sleeping volunteers inside an MRI scanner, timed to the peaks of those slow waves.
The sounds made the slow waves stronger, and fluid flow rose to match.
Why it matters
Poor fluid flow is a feature of some brain diseases, so the authors see a possible treatment.
The full story
Sounds during sleep moved brain fluid
During deep sleep, the fluid around the brain and spinal cord moves in large waves, in time with slow brain waves.
Why it matters. Poor fluid flow is a feature of some brain diseases, so the authors see a possible treatment.
Organs look youngest on about seven hours' sleep
Swipe up for the story ↑Scroll down for the story ↓
A study in Nature in May compared how long UK Biobank volunteers aged 37 to 84 said they slept with 23 measures of how old their organs looked.
The pattern was a U: short and long sleepers both looked older inside.
Under six hours or over eight went with more depression, diabetes and deaths.
Why it matters
Sleep length was self-reported.
1 source
Organs look youngest on about seven hours' sleep
The full story
Organs look youngest on about seven hours' sleep
A study in Nature in May compared how long UK Biobank volunteers aged 37 to 84 said they slept with 23 measures of how old their organs looked.
Why it matters. Sleep length was self-reported.
One malaria drug does most of the work
Swipe up for the story ↑Scroll down for the story ↓
Each malaria season millions of African children take two malaria drugs together, sulfadoxine-pyrimethamine and amodiaquine, to prevent infection.
A study pooled blood tests from 934 children in Uganda, Mozambique and Burkina Faso.
Children with low levels had nearly twice the risk of infection by day 28.
Why it matters
The other drug showed only weak links in all three countries, whatever resistance genes their parasites carried.
1 source
One malaria drug does most of the work
The full story
One malaria drug does most of the work
Each malaria season millions of African children take two malaria drugs together, sulfadoxine-pyrimethamine and amodiaquine, to prevent infection.
Why it matters. The other drug showed only weak links in all three countries, whatever resistance genes their parasites carried.
How Ozempic's drug protects kidneys is still open
Swipe up for the story ↑Scroll down for the story ↓
Semaglutide, the drug sold as Ozempic and Wegovy, is known to protect the kidneys of people with type 2 diabetes and kidney disease.
A 52-week trial in 106 such people scanned their kidneys before and after, and took samples from some, to find out how.
Its three main scan measures, oxygen, blood flow and inflammation, did not change.
Why it matters
The trial was built to explain the kidney benefit.
2 sources
How Ozempic's drug protects kidneys is still open
The full story
How Ozempic's drug protects kidneys is still open
Semaglutide, the drug sold as Ozempic and Wegovy, is known to protect the kidneys of people with type 2 diabetes and kidney disease.
Why it matters. The trial was built to explain the kidney benefit.
CPAP lowered signs of inflammation
Swipe up for the story ↑Scroll down for the story ↓
In sleep apnoea a person stops breathing for 10 seconds or more during sleep, and a CPAP machine is one treatment.
A review published on 1 October pooled trials in adults starting CPAP.
The evidence was rated low certainty.
Why it matters
A possible drop in insulin resistance did not hold up when the authors checked how solid it was.
2 sources
CPAP lowered signs of inflammation
The full story
CPAP lowered signs of inflammation
In sleep apnoea a person stops breathing for 10 seconds or more during sleep, and a CPAP machine is one treatment.
Why it matters. A possible drop in insulin resistance did not hold up when the authors checked how solid it was.
Arthritis pain that outlasts the inflammation
Swipe up for the story ↑Scroll down for the story ↓
In rheumatoid arthritis, a disease that inflames the joints, many patients still hurt after drugs have brought the inflammation down to low levels.
A review of studies, published in January in the journal Cureus by Japanese researchers, found that adding more anti-inflammatory drugs often did not fix that pain.
Some drugs that block the immune signal IL-6 helped a little in some patients.
Why it matters
The authors say the gap points to causes beyond the inflamed joint.
1 source
Arthritis pain that outlasts the inflammation
The full story
Arthritis pain that outlasts the inflammation
In rheumatoid arthritis, a disease that inflames the joints, many patients still hurt after drugs have brought the inflammation down to low levels.
Why it matters. The authors say the gap points to causes beyond the inflamed joint.
Social anxiety and the habits that feed it
Swipe up for the story ↑Scroll down for the story ↓
Social anxiety disorder affects up to 12% of people at some point in their lives, the BBC reported on 30 September.
Research by the universities of Chichester, Coventry and UCL linked it to lower grades and poorer relationships among students, more than a fifth of whom face some social anxiety.
A talking therapy called CBT is considered the best treatment, and the NHS offers it.
Oxford psychologist David Clark says habits that feel protective, such as rehearsing every sentence or avoiding eye contact, make it worse.
Why it matters
Social Anxiety Alliance UK says many people treat it as a personality flaw rather than as a condition that can be treated.
1 source
Social anxiety and the habits that feed it
The full story
Social anxiety and the habits that feed it
Social anxiety disorder affects up to 12% of people at some point in their lives, the BBC reported on 30 September.
Why it matters. Social Anxiety Alliance UK says many people treat it as a personality flaw rather than as a condition that can be treated.
Weekend exercise and arthritis
Swipe up for the story ↑Scroll down for the story ↓
Researchers used wrist activity trackers from 70,608 UK Biobank volunteers to compare people who pack at least half their weekly exercise into two days with people who spread it out.
Both groups had a lower overall risk of osteoarthritis, a joint disease, than inactive people.
The people who packed it in had a 21% higher risk of osteoarthritis in the hands.
Why it matters
It is an observational study, so it cannot show that packing exercise into two days causes hand arthritis.
1 source
Weekend exercise and arthritis
The full story
Weekend exercise and arthritis
Researchers used wrist activity trackers from 70,608 UK Biobank volunteers to compare people who pack at least half their weekly exercise into two days with people who spread it out.
Why it matters. It is an observational study, so it cannot show that packing exercise into two days causes hand arthritis.
Emotion, recorded one brain cell at a time
Swipe up for the story ↑Scroll down for the story ↓
The amygdala and the hippocampus are two brain areas central to emotion.
Short bursts of brain waves in the amygdala changed how some hippocampus cells fired.
Why it matters
The authors say these bursts could become a target for brain stimulation.
1 source
Emotion, recorded one brain cell at a time
The full story
Emotion, recorded one brain cell at a time
The amygdala and the hippocampus are two brain areas central to emotion.
Why it matters. The authors say these bursts could become a target for brain stimulation.
Implants that talk through the body
Swipe up for the story ↑Scroll down for the story ↓
Implants such as insulin pumps often need a signal from one part of the body to act in another, and that usually travels by Bluetooth.
A team reported in Science a system called SWANS that sends faint electrical pulses through body tissue instead.
In rats, a movement of a front paw sent a pulse that switched on an implant, which made a hind leg flex.
Why it matters
Bluetooth needs a bulky battery, so pulses through tissue could let small sensors sit deep in the gut or muscles.
The full story
Implants that talk through the body
Implants such as insulin pumps often need a signal from one part of the body to act in another, and that usually travels by Bluetooth.
Why it matters. Bluetooth needs a bulky battery, so pulses through tissue could let small sensors sit deep in the gut or muscles.
A father rat's early stress showed up in his daughters
Swipe up for the story ↑Scroll down for the story ↓
Male rats separated from their mothers early in life, some also fed a high-fat diet, were bred with unstressed females.
Their daughters behaved differently in a maze used to test anxiety, and the fathers' sperm carried chemical marks on many genes.
Some of those genes were also changed in the daughters' amygdala, a brain area central to stress.
Why it matters
It suggests a father's early stress may pass to offspring through sperm, not only through upbringing.
1 source
A father rat's early stress showed up in his daughters
The full story
A father rat's early stress showed up in his daughters
Male rats separated from their mothers early in life, some also fed a high-fat diet, were bred with unstressed females.
Why it matters. It suggests a father's early stress may pass to offspring through sperm, not only through upbringing.
That's the whole Mind & body day.
29 stories, 38 sources.